FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β

Citations of this article
Mendeley users who have this article in their library.


Aberrant activation of Wnt/β-catenin signaling plays an unequivocal role in colorectal cancer, but identification of effective Wnt inhibitors for use in cancer remains a tremendous challenge. New insights into the regulation of this pathway could reveal new therapeutic point of intervention, therefore are greatly needed. Here we report a novel FAK/PYK2/GSK3β<sup>Y216</sup>/β-catenin regulation axis: FAK and PYK2, elevated in adenomas in APC<sup>min/+</sup> mice and in human colorectal cancer tissues, functioned redundantly to promote the Wnt/β-catenin pathway by phosphorylating GSK3β<sup>Y216</sup> to reinforce pathway output—β-catenin accumulation and intestinal tumorigenesis. We previously showed that Wnt-induced β-catenin accumulation requires Wnt-induced GSK3β/β-TrCP interaction; the current study revealed that phosphorylation of GSK3β<sup>Y216</sup> was a molecular determinant of GSK3β recruitment of β-TrCP. Pharmacological inhibition of FAK/PYK2 suppressed adenoma formation in APC<sup>min/+</sup> mice accompanied with reduced intestinal levels of phospho-GSK3β<sup>Y216</sup> and β-catenin, indicating that FAK/PYK2/GSK3β<sup>Y216</sup> axis is critical for the activation of Wnt/β-catenin signaling in APC driven intestinal tumorigenesis.




Gao, C., Chen, G., Kuan, S. F., Zhang, D. H., Schlaepfer, D. D., & Hu, J. (2015). FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β. ELife, 4(AUGUST2015). https://doi.org/10.7554/eLife.10072

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free